Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin
- 1 December 1998
- journal article
- research article
- Published by Elsevier in The American Journal of Surgery
- Vol. 176 (6) , 74S-79S
- https://doi.org/10.1016/s0002-9610(98)00224-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Treatment of acute gynecologic infections with trovafloxacinThe American Journal of Surgery, 1998
- Oral trovafloxacin compared with intravenous cefoxitin in the prevention of bacterial infection after elective vaginal or abdominal hysterectomy for nonmalignant diseaseThe American Journal of Surgery, 1998
- Double-blind comparison of single-dose alatrofloxacin and cefotetan as prophylaxis of infection following elective colorectal surgeryThe American Journal of Surgery, 1998
- The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjectsThe American Journal of Surgery, 1998
- Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatinThe American Journal of Surgery, 1998
- Fluoroquinolones exhibit differences in their incidence of rare adverse effectsDrugs & Therapy Perspectives, 1996
- Pharmacokinetics and safety of trovafloxacin (CP-99, 219), a new quinolone antibiotic, following adminstration of single oral doses to healthy male volunteersJournal of Antimicrobial Chemotherapy, 1995
- In vitro activity of the new fluoroquinolone CP-99,219Antimicrobial Agents and Chemotherapy, 1994
- Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobesAntimicrobial Agents and Chemotherapy, 1994
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1993